Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Currie

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Child and Adolescent Psychiatry and Mental Health|October 15, 2013
The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010)Sarah E Holden, Sara Jenkins-Jones, Chris D Poole, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 11, 2018
Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective StudyChristopher Ll Morgan, Qing Qiao, Susan Grandy, et al.
Clinical Therapeutics|March 15, 2011
Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database studyChristopher Ll Morgan, Marc Evans, Anders D Toft, et al.
Current Medical Research and Opinion|June 15, 2007
An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosisJaroslaw Wechowski, Mark Connolly, Anette Woehl, et al.
The Journal of Clinical Endocrinology and Metabolism|October 19, 2012
What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetesChristopher Ll Morgan, Chris D Poole, Marc Evans, et al.
Diabetes, Obesity & Metabolism|February 21, 2017
Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort studySarah E Holden, Christopher Ll Morgan, Qing Qiao, et al.
BJU International|May 12, 2006
The impact of the overactive bladder on health-related utility and quality of lifeCraig J Currie, Phil McEwan, Chris D Poole, et al.
Clinical and Experimental Rheumatology|September 6, 2014
Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugsPaul Emery, Gaia Gallo, Helen Boyd, et al.
Expert Review of Clinical Immunology|November 28, 2019
Evaluation of the epidemiology of peanut allergy in the United KingdomLaura A Scott, Bethan I Jones, Thomas R Berni, et al.
Current Medical Research and Opinion|September 28, 2019
Cough presentation in primary care and the identification of chronic cough: a need for diagnostic clarity?Sarah E Holden, Alyn Morice, Surinder S Birring, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Child and Adolescent Psychiatry and Mental Health|October 15, 2013
The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010)Sarah E Holden, Sara Jenkins-Jones, Chris D Poole, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 11, 2018
Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective StudyChristopher Ll Morgan, Qing Qiao, Susan Grandy, et al.
Clinical Therapeutics|March 15, 2011
Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database studyChristopher Ll Morgan, Marc Evans, Anders D Toft, et al.
Current Medical Research and Opinion|June 15, 2007
An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosisJaroslaw Wechowski, Mark Connolly, Anette Woehl, et al.
The Journal of Clinical Endocrinology and Metabolism|October 19, 2012
What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetesChristopher Ll Morgan, Chris D Poole, Marc Evans, et al.
Diabetes, Obesity & Metabolism|February 21, 2017
Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort studySarah E Holden, Christopher Ll Morgan, Qing Qiao, et al.
BJU International|May 12, 2006
The impact of the overactive bladder on health-related utility and quality of lifeCraig J Currie, Phil McEwan, Chris D Poole, et al.
Clinical and Experimental Rheumatology|September 6, 2014
Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugsPaul Emery, Gaia Gallo, Helen Boyd, et al.
Expert Review of Clinical Immunology|November 28, 2019
Evaluation of the epidemiology of peanut allergy in the United KingdomLaura A Scott, Bethan I Jones, Thomas R Berni, et al.
Current Medical Research and Opinion|September 28, 2019
Cough presentation in primary care and the identification of chronic cough: a need for diagnostic clarity?Sarah E Holden, Alyn Morice, Surinder S Birring, et al.
Pageof 10